The use of sacubitril/valsartan appears feasible and safe in recipients of left ventricular assist devices, reducing the need ...
PONTE VEDRA, Fla.--(BUSINESS WIRE)--Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) today recapped its 2024 milestones and highlighted a clear path forward to develop the investigational drug tecarfarin as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback